dual 5-HT2a/5-HT2b antagonists (GlaxoSmithKline)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namedual 5-HT2a/5-HT2b antagonists (GlaxoSmithKline)
Drug Alias Namedual 5-HT2a/5-HT2b antagonists (GlaxoSmithKline)5-HT2b antagonists (GlaxoSmithKline)GSK-1645888GSK-2054757SB-742888 +[8] 
ClassificationSmall molecules
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsSerotonin 2b (5-HT2b) receptor antagonists
TargetsSerotonin 2b (5-HT2b) receptorSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsPainFibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsPainFibrosis

Other Information

ATC CodeN/A
Related LinksN/A